IL15RA and neoplasm: Though there was not an apparent advantage in using IL-15/IL-15Rα over IL-15 alone, or high levels of IL-15 over low levels of IL-15 to induce tumor regression of the treated tumor and long-term survival, it became clear upon challenge that high levels of IL-15 do not protect from challenge and a lower expression induces specific anti-tumor responses.